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Objective: To compare fat distribution and associations between fat depots and cardiometabolic traits in
South Asians and Europeans.
Methods: Five hundred and fourteen South Asians and 669 Europeans, aged 56-86. Questionnaires,
record review, blood testing, and coronary artery calcification scores provided diabetes and clinical plus
subclinical coronary heart disease (CHD) diagnoses. Abdominal visceral (VAT) and subcutaneous adipose
tissue, thigh subcutaneous adipose tissue (TSAT), intermuscular and intramuscular thigh fat and thigh
muscle were measured by CT.
Results: Accounting for body size, South Asians had greater VAT and TSAT than Europeans, but less
thigh muscle. Associations between depots and disease were stronger in South Asians than Europeans.
In multivariable analyses in South Asians, VAT was positively associated with diabetes and CHD, while
TSAT and thigh muscle were protective for diabetes, and thigh muscle for CHD. Differences in VAT and
thigh muscle only partially explained the excess diabetes and CHD in South Asians versus Europeans.
Insulin resistance did not account for the effects of TSAT or thigh muscle.
Conclusions: Greater VAT and TSAT and lesser thigh muscle in South Asians contributed to ethnic differen-
ces in cardiometabolic disease. Effects of TSAT and thigh muscle were independent of insulin resistance.
Obesity (2014) 22, 2071–2079. doi:10.1002/oby.20796
Introduction
Obesity is a key risk factor for burgeoning global levels of diabetes
and cardiovascular disease, and central deposition of adipose tissue
appears particularly harmful (1,2). Urbanized South Asian popula-
tions, resident in the Indian subcontinent and settled overseas, experi-
ence greater rates of cardiometabolic disease [diabetes, coronary heart
disease (CHD) and stroke] than European populations (3,4), and eth-
nic differences in body composition may contribute to this (5,6).
Computer tomographic (CT) or magnetic resonance (MR) imaging
can differentiate abdominal depots into visceral adipose tissue
(VAT) and subcutaneous adipose tissue (SAT) compartments, and
quantify depots outside the abdomen that may contribute to cardio-
metabolic risk. South Asians have greater VAT in some (7-10), but
not all studies (11), less lower limb skeletal muscle (10), and less
intramuscular adipose tissue than Europeans (9). In Europeans, thigh
subcutaneous adipose tissue (TSAT) and thigh muscle have benefi-
cial, and thigh inter- and intramuscular adipose tissue deleterious
effects on insulin resistance (12-15), HbA1c (16) and inflammation
(17,18). There is a paucity of comparable data for South Asians.
Previous studies comparing fat and muscle in South Asians and
Europeans are limited by small numbers, exclusion of those with
disease or medications, and recruitment by advertisement rather than
population sampling (7-11). These factors may introduce bias by
ethnicity, as disease and medication use differ markedly by ethnic-
ity, making recruits unrepresentative of the population from which
they came, and thus findings less generalizable.
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We compared fat depots of the abdomen and thigh, as well as thigh
muscle, in South Asians and Europeans, examined individual and
combined associations with risk factors and cardiometabolic disease
by ethnicity and determined whether body fat distribution accounted
for ethnic differences in cardiometabolic disease.
Methods
Study sample
We used cross-sectional follow-up data from the Southall And Brent
REvisited (SABRE) study, a population-based cohort of individuals
from north-west London (19). All South Asians were first-
generation migrants, 82% were born in the Indian subcontinent and
14% in East Africa. Participants aged 40-69 (n 5 4857) were ran-
domly selected from age- and gender-stratified general practitioner
lists and workplaces at baseline (1988–1991), and were followed-up
between 2008 and 2011, aged 56-85 years (n 5 4196). This analysis
is restricted to 669 European and 514 South Asian participants who
attended follow-up clinic (2008–2011). All participants gave written
informed consent. Study approval was obtained from St Mary’s Hos-
pital Research Ethics Committee (07/H0712/109).
Clinic measurements
Fasting blood samples were taken. Participants without diabetes
underwent an oral glucose tolerance test. HOMA2-IR (20) and the
Matsuda index (21) were used as measures of insulin resistance. For
details of lipid, glucose, insulin, HbA1c, CRP, and IL-6 assays, see
supplementary file.
Physical activity comprised the total weekly energy expended (MJ)
on sports, walking, cycling and daily activities, using questions
based on the Allied Dunbar fitness survey (22) and energy expendi-
ture estimates based on work by Durnin and Passmore (23,24).
At follow-up, measurements were undertaken by trained researchers
at St Mary’s Hospital London. Height was measured barefoot using
a stadiometer, and weight wearing a hospital gown, using a Tanita
TBF-410 MA body composition analyzer. This calculated fat %, fat
mass (kg), and total weight (kg). BMI was calculated as weight
(kg)/height(m)2. Waist circumference was measured halfway
between the costal margin and the iliac crest. Hip circumference
was measured at the greater trochanter. Thigh circumference was
measured halfway between the hip crease and the patella.
Abdominal and mid-thigh fat, and thigh muscle, were measured by
computer tomography (CT) scan at 125kV with a Philips MX 8000
IDT64 detector. Images were taken with the participant supine with
extended arms. VAT, and abdominal deep and superficial subcutane-
ous adipose tissue (DSAT, SSAT) were quantified from a single
slice image of 10 mm thickness at the fourth lumbar vertebral level.
We applied an attenuation range of 2190 to 230 Hounsfield units
(HU) to identify adipose tissue areas. VAT area was measured by
circumscribing the visceral compartment manually [using Image-J
software (25)]. The abdominal fascial layer was demarcated, to ena-
ble calculation of DSAT and SSAT. A slice at mid-thigh level was
used to quantify thigh fat and muscle areas. Muscle perimeter was
delineated by an automated function. Thigh intermuscular adipose
tissue (TIMAT) corresponded to the area in the attenuation range
2190 to 230 HU, intramuscular or low attenuation muscle (LAM)
to the area in the attenuation range 0-30 HU, and thigh muscle area
of normal fat content (referred to as “thigh muscle” in analyses) to
the area in the attenuation range 30-100 HU, as previously described
(26). TSAT was then calculated by subtracting TIMAT from the
total thigh area within the attenuation range 2190 to 230 HU.
Bone marrow fat was excluded. Right and left leg values were
summed. Intra-observer reliability of VAT, SAT, TIMAT, and thigh
muscle measurements was tested by comparing repeated measure-
ments on 30 participants; coefficients of variation were 0.95%,
0.68%, 1.8%, and 2.7%, respectively.
Cardiac CT scanning was performed from the ascending aorta above
the level of the coronary arteries to the inferior border of the heart.
Transverse tomograms of 2.5 mm thickness were obtained with the
participant in held inspiration. Coronary artery calcification (CAC)
was quantified using proprietary software on a Philips Extended
Brilliance computer workstation, and calcification was defined as an
area >1 mm2 of density >130 HU. The CAC score was calculated
as the sum of all lesion scores [Agatston Units (AU)]. Scans were
read by a single experienced observer blinded to participant ethnic-
ity. Inter-observer reproducibility, comparing scores from a senior
investigator (AW), and intra-observer reproducibility were assessed
initially and at intervals during follow-up, using the same 20 CT
scans. The intra-class correlation coefficient for intra and inter-
observer measurements was 0.94.
Identification of diabetes and CHD
Diabetes was identified from primary care record review (recorded
diagnosis or medications for diabetes), participant questionnaire
(recall of physician-diagnosed diabetes plus diagnosis year or diabe-
tes medication) or, in those with undiagnosed diabetes, raised oral
glucose tolerance test plasma glucose by WHO 1999 criteria (27).
CHD was defined from primary care record review adjudicated by
two clinicians—diagnosis was based on symptoms, cardiac enzymes,
electrocardiography findings, exercise test findings, and coronary
revascularization procedures, as per ASCOT (Anglo-Scandinavian
Cardiac Outcomes Trial) criteria (28). Sub-clinical CHD was classi-
fied as a CAC score>400 AU (29) in those without diagnosed
CHD. We used a composite measure of diagnosed CHD and sub-
clinical CHD to address ethnic presentation/ diagnostic bias and to
maximize power.
Statistical analyses
Descriptive statistics were calculated for demographics, body com-
position, and cardiometabolic risk factors by gender and ethnicity.
ANOVA and chi-squared tests determined ethnic group differences.
Associations between body composition measures were assessed by
Spearman’s correlation coefficients.
Linear and logistic regression models examined associations
between body composition measures and four cardiometabolic traits:
diabetes, HbA1c, clinical and subclinical CHD (composite trait), and
CRP. These were selected to represent prevalent disease (diabetes,
CHD), and one continuous variable (HbA1c and CRP) associated
with each disease known to be influenced by fat distribution. We
examined age-adjusted univariate associations between body compo-
sition and cardiometabolic traits stratified by ethnicity. Interactions
between ethnicity and associations of body composition measures
with cardiometabolic traits were sought.
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Multivariable analyses showed combined associations between body
composition measures and cardiometabolic traits by ethnicity. Meas-
ures with the strongest effects (i.e. largest standardized beta in uni-
variate analyses) were entered first, and others included sequentially
and retained according to the size of effect and statistical signifi-
cance. The final multivariable models contained only variables
which were important associates of cardiometabolic traits for at least
one ethnic group (P < 0.05); enabling cross-ethnic group compari-
son. Secondary models included HOMA2-IR (selected in preference
to the Matsuda index as it best attenuated associations between body
composition measures and cardiometabolic traits).
Finally we evaluated the ability of body composition variables to account
for ethnic differences in diabetes and CHD. For these analyses, variables
significantly associated with cardiometabolic traits in the previous
ethnicity-stratified multivariable analysis were entered and retained
according to their impact on accounting for the ethnic difference (repre-
sented by an odds ratio for the association of South Asian ethnicity with
cardiometabolic traits). Significant (P < 0.05) ethnicity/body composi-
tion interactions from multivariable models were additionally entered
into models. Final models were adjusted for HOMA2-IR.
To test for multicollinearity, we examined variance inflation factors
(VIFs), using a threshold of VIF > 5 to indicate model instability
(30). Sensitivity analyses were performed by additionally adjusting
multivariable models for years of education, physical activity, resting
heart rate, inflammatory markers (CRP and IL-6), and lipids (HDL,
LDL and triglycerides) in turn. Additionally, as it has been suggested
that ethnic differences in HbA1c exist even after adjustment for meta-
bolic risk factors (31), we repeated analyses using fasting glucose
instead of HbA1c. Sub-group analyses stratified by diabetes status,
gender, and age group (younger: 56-72 years, older: 73-86 years).
Analyses were performed using Stata 12 (College Station, Texas).
Results
South Asians had more diabetes, lower levels of physical activity,
greater hyperglycaemia and insulinaemia, and a greater burden of
clinical and subclinical CHD than Europeans (Table 1).
South Asians were shorter, lighter with smaller body circumferences
(Table 2). However, larger waist:hip and waist:thigh ratios in South
Asians, compared to Europeans, indicated a tendency towards
greater central fat deposition in the former. Crude CT measures of
VAT were greater in European than South Asian men, while DSAT,
SSAT, and TSAT did not differ. But South Asians were shorter and
TABLE 1 Demographics and cardiometabolic traits, by sex and ethnicity
Men Women
European South Asian Pa European South Asian Pa
n 517 439 - 152 75 -
Age, years 70 6 6 69 6 6 0.01 69 6 6 68 6 6 0.19
Ever smoked, % 67 25 <0.001 51 5.0 <0.001
Physical activity, MJ/week 10.4 6 4.7 9.6 6 4.5 0.02 8.7 6 3.8 7.4 6 3.2 0.03
Diabetes, % 19 44 <0.0001 20 36 0.05
Diabetes treatment, % 11 33 <0.001 9 21 0.01
HbA1c, % 5.9(5.7-6.2) 6.3(5.9-7.0) <0.0001 5.8(5.6-6.1) 6.1(5.9-6.8) <0.0001
HbA1c, mmol/mol 41(39-44) 45(41-53) <0.0001 40(38-43) 43(41-51) <0.0001
Fasting blood glucose, mmol/l 5.1(4.8-5.6) 5.4(4.8-6.2) <0.0001 4.9(4.7-5.4) 5.1(4.6-6.0) 0.62
Fasting blood insulin, mIU/ ml 9.0(5.7-13.7) 9.8(6.4-15.5) 0.08 7.7(5.0-11.0) 8.9(5.6-13.3) 0.29
HOMA2-IRb 1.15(0.70-1.70) 1.10(0.70-1.80) 0.83 0.90(0.60,1.30) 1.15(0.80,1.75) 0.01
Matsuda index of insulin resistanceb 0.22(0.14-0.37) 0.30(0.20-0.53) 0.0001 0.22(0.13-0.31) 0.35(0.18,0.5) 0.0003
Total cholesterol, mmol/l 4.73 6 1.10 4.39 6 1.00 <0.0001 5.37 6 1.10 4.93 6 1.31 0.01
HDL-cholesterol, mmol/l 1.33 6 0.3 1.27 6 0.30 0.001 1.57 6 0.38 1.48 6 0.32 0.11
Triglycerides, mmol/l 1.18(0.86-1.58) 1.20(0.90-1.65) 0.14 1.18(0.87-1.58) 1.23(0.95,1.65) 0.31
Lipid-lowering treatment, % 52 69 <0.001 38 64 <0.001
CAC score >400 AUc, % 26 27 0.96 13 9 0.37
Diagnosed CHD, % 18 30 0.001 6 23 0.001
Clinical or subclinical CHDd, % 37 46 0.005 16 30 0.02
IL-6, pg/ml 1.9(1.6-2.1) 1.7(1.4-1.9) 0.30 1.7(1.3-2.0) 1.2(1.0-1.3) 0.78
CRP, mmol/ l 1.6(0.9-3.2) 1.3(0.6-5.3) 0.88 2.0(0.8-4.2) 2.3(1.1-4.6) 0.88
Data are mean 6 SD or median(IQR) for continuous variables.
aP for ethnic difference.
bparticipants without diabetes, CAC5coronary artery calcification, AU5Agatston units.
cparticipants without diagnosed coronary heart disease (CHD).
ddefined as CAC score >400AU in those without diagnosed CHD, or CHD.
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had less total fat mass than Europeans, and when these factors were
accounted for, South Asians had more VAT, DSAT, SSAT, and
TSAT than Europeans. TIMAT and low attenuation (“fat-rich”)
muscle (LAM) were lower in South Asians than Europeans; these
differences persisted when the lesser amount of thigh muscle in
South Asians was accounted for. Ethnic differences in thigh muscle
area, TIMAT, or LAM persisted within tertile of physical activity
(data not shown). However, when adjusted for height and fat mass,
there were no ethnic differences in TIMAT and LAM. Correlations
between body composition variables were similar in each ethnic
group (Table S1, Supporting Information).
Taken separately, fat depots were positively associated with cardio-
metabolic risk factors (Figure 1), with VAT generally showing the
strongest associations. Thigh muscle area was negatively associated
with all cardiometabolic traits, significantly so in South Asians for
diabetes, HbA1c, and clinical and subclinical CHD.
In multivariable models, VAT was the strongest independent corre-
late of diabetes, HbA1c, clinical and subclinical CHD and CRP,
more so in South Asians than Europeans for HbA1c (P 5 0.01 for
interaction) (Table 3). After adjustment for VAT, TSAT became
inversely associated with diabetes and HbA1c in South Asians, and
SSAT inversely associated with HbA1c in Europeans, reversing posi-
tive univariate associations; all these were significant as interactions.
Thigh muscle area largely retained inverse associations with diabe-
tes, HbA1c, clinical and subclinical CHD and CRP, an effect greater
for South Asians than Europeans for metabolic traits. Additional
adjustment for HOMA2-IR (Table 2), only attenuated VAT associa-
tions with clinical and subclinical CHD; associations remained sig-
nificant for diabetes, HbA1c and CRP. Furthermore, associations
between other depots and all cardiometabolic traits remained as
described above after adjustment for HOMA2-IR. TIMAT and LAM
were not independently associated with cardiometabolic traits in
multivariable models.
We then examined whether body composition could account for eth-
nic differences in disease (Table 4). Ethnicity interaction terms were
used for TSAT and thigh muscle in diabetes (but not CHD) models,
in accordance with the above findings. VAT and separately thigh
muscle attenuated the South Asian diabetes excess from an odds
ratio of 3.78(2.80,5.10) to 3.56(2.62,4.83) and to 3.14(2.28,4.32),
respectively, while TSAT increased it to 4.13(3.03,5.65). The effects
of VAT were partly explained by insulin resistance, though those of
TABLE 2 Body composition measures, by sex and ethnicity
Men Women
European South Asian Pa European South Asian Pa
Height (cm) 173 6 7 167 6 6 <0.0001 160 6 6 153 6 6 <0.0001
Weight (kg) 84 6 15 74 6 12 <0.0001 72 6 16 66 6 12 0.001
BMI (kg/m2 28 6 4 26 6 4 <0.0001 28 6 5 28 6 5 0.85
Waist circumference (cm) 101 6 12 99 6 10 0.0001 94 6 13 96 6 11 0.31
Waist:hip 0.99 6 0.6 1.01 6 0.06 <0.0001 0.90 6 0.07 0.95 6 0.09 0.0002
Waist:thigh ratio 1.97 6 0.18 1.99 6 0.19 0.09 1.74 6 0.21 1.82 6 0.24 0.009
Total fat mass (kg) 23 6 9 19 6 7 <0.0001 28 6 11 25 6 9 0.02
Fat free mass (kg) 60 6 8 55 6 6 <0.0001 44 6 6 41 6 7 0.002
Total fat % 27 6 6 26 6 6 0.001 38 6 7 37 6 7 0.43
Abdominal visceral adipose tissue (cm2) 245 6 104 228 6 89 0.01 156 6 75 162 6 65 0.50
Adjusted for age, height, fat mass 230 6 104 244 6 89 0.0003 158 6 75 174 6 65 0.04
Abdominal deep subcutaneous adipose tissue (cm2) 147 6 62 151 6 58 0.25 147 6 62 159 6 64 0.19
Adjusted for age, height, fat mass 136 6 62 162 6 58 <0.0001 151 6 62 166 6 64 0.05
Abdominal superficial subcutaneous adipose tissue (cm2) 76 6 33 77 6 32 0.47 144 6 67 158 6 66 0.13
adjusted for age, height, fat mass 71 6 33 81 6 32 <0.0001 149 6 67 166 6 66 0.0006
Thigh subcutaneous adipose tissue (cm2) 115 6 53 114 6 52 0.69 230 6 103 253 6 102 0.12
adjusted for age, height, fat mass 108 6 53 121 6 52 <0.0001 237 6 103 262 6 102 0.02
Thigh intermuscular adipose tissue (cm2) 5.5 6 3.6 4.8 6 2.8 0.0006 3.9 6 2.7 3.9 6 2.9 0.90
adjusted for age, thigh muscle area 5.7 6 3.6 4.3 6 2.8 <0.0001 4.0 6 2.7 3.0 6 2.9 0.02
adjusted for age, height, fat mass 5.1 6 2.7 5.2 6 2.7 0.48 4.0 6 2.3 4.3 6 2.5 0.58
Thigh low attenuation muscle (cm2) 46 6 22 40 6 18 0.0001 35 6 17 35 6 14 0.94
adjusted for age, thigh muscle area 47 6 22 36 6 18 <0.0001 35 6 17 30 6 14 0.03
adjusted for age, height, fat mass 43 6 18 43 6 18 0.74 35 6 15 39 6 16 0.15
Thigh muscle (cm2) 214 6 41 185 6 37 <0.0001 151 6 26 118 6 27 <0.0001
adjusted for age, height 212 6 37 186 6 37 <0.0001 149 6 27 121 6 29 <0.0001
Data are mean 6 SD.
aP for ethnic difference, thigh measurements are right 1 left leg.
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TSAT and thigh muscle were not. For the South Asian excess of
CHD [OR 1.76(1.33,2.33)], thigh muscle appeared to better account
for the ethnic difference [OR 1.50(1.12,2.02) than VAT (OR
1.71(1.29,2.27)]. The effects of VAT, but not thigh muscle appeared
attenuated when HOMA2-IR was entered into the model.
There was no indication of multicollinearity in multivariable models.
Results were similar when multivariable models were adjusted for
years of education, physical activity, resting heart rate, inflammatory
markers, or lipids. Additionally, replacing fasting glucose with
HbA1c produced identical results. Sub-group analyses demonstrated
persistence of patterns, regardless of diabetes status, gender, or
younger/ older age group.
Discussion
South Asians had more visceral and subcutaneous abdominal and
thigh fat than Europeans, even when their smaller frame size was
accounted for. VAT had the greatest adverse impact on cardiometa-
bolic risk factors and disease, while TSAT and thigh muscle were
Figure 1 Associations between body composition measures and cardiometabolic risk by ethnicity: (a) Diabetes, (b) HbA1c, (c) Clinical 1 subclinical
CHD, and (d) CRP. OR/standardized b for a 1SD increase of independent variables, adjusted for age and sex, 95% confidence intervals indicated by
vertical lines, *ethnicity/ body composition measure interaction P < 0.05,VAT, abdominal visceral adipose tissue; DSAT, abdominal deep subcutane-
ous adipose tissue; SSAT, abdominal superficial subcutaneous adipose tissue; TSAT, thigh subcutaneous adipose tissue; TIMAT, thigh intermuscular
adipose tissue; LAM, low attenuation muscle. HbA1c,CRP,VAT, DSAT, SSAT, TSAT, TIMAT, LAM log-transformed.
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independently protective. Adverse effects of VAT on HbA1c, and
protective effects of TSAT and thigh muscle on diabetes and HbA1c
were stronger in South Asians than in Europeans. Ethnic differences
in VAT, TSAT, and thigh muscle contributed to, but only partly
accounted for, ethnic differences in diabetes and CHD. Effects of
TSAT and thigh muscle were independent of insulin resistance.
We accounted for ethnic differences in body frame size and depot-
specific lean mass when comparing ethnic differences in fat depots.
It was only after allowing for their shorter height and lesser total fat
mass that we found South Asians had relatively more VAT, DSAT,
SSAT, and TSAT than Europeans. This is a standard approach when
using surface anthropometry, for example by indexing waist circum-
ference to hip circumference or height, and is recognized by some
previous studies of ethnic differences in abdominal fat using imag-
ing, comparing African American and white American populations
(32). Comparisons between South Asians and Europeans have gener-
ally not employed this method, but some matched on BMI or weight
and thus may have allowed for body size differences (8,10).
Our findings of greater VAT in South Asians than Europeans are con-
sistent with most (7-10), but not all studies (11). We are not aware of
other studies comparing CT-measured TSAT in South Asians and
Europeans, though larger thigh skinfolds in South Asians have been
previously reported (33). We expected South Asians to have higher
intermuscular (TIMAT) and intramuscular (LAM) fat than Europeans,
as these depots are thought to have adverse effects on metabolic risk
(12,13). However, South Asians had less of both the depots, or similar
amounts when differences in height and fat mass were accounted for,
when compared with Europeans. Consequently, we considered the
possibility that Europeans may have had more inter/intramuscular fat
than South Asians because of their higher levels of physical exercise
TABLE 3 Multivariable associations between body composition measures, insulin resistance and cardiometabolic traits, by
ethnicity
Europeans South Asians
Cardiometabolic traits Model factors b/ OR 95% CI p b/ OR 95% CI p pa
Diabetes VAT 2.07 1.44,2.97 <0.001 2.10 1.53,2.89 <0.001 0.45
TSAT 0.77 0.53,1.12 0.18 0.45 0.31,0.66 <0.001 0.002
Thigh muscle 0.87 0.66,1.16 0.35 0.45 0.33,0.62 <0.001 0.04
Diabetes VAT 1.80 1.23,2.63 0.002 1.58 1.13,2.23 0.008 0.85
TSAT 0.74 0.50,1.08 0.12 0.46 0.31,0.68 <0.001 0.002
Thigh muscle 0.85 0.65,1.13 0.27 0.43 0.31,0.59 <0.001 0.03
HOMA2-IR 1.44 1.11,1.86 0.007 1.75 1.36,2.26 <0.001 0.26
HbA1c VAT 0.17 0.09,0.26 <0.001 0.33 0.19,0.47 <0.001 0.002
SSAT 20.15 20.27,0.03 0.01 0.07 20.15,0.30 0.52 0.02
TSAT 0.08 20.05,0.21 0.21 20.42 20.64,20.20 <0.001 <0.001
Thigh muscle 20.04 20.12,0.04 0.31 20.31 20.45,20.17 <0.001 0.003
HbA1c VAT 0.11 0.02,0.20 0.02 0.16 0.02, 0.30 0.03 0.56
SSAT 20.11 20.23,0.01 0.05 0.06 20.16,0.28 0.58 0.08
TSAT 0.05 20.08,0.18 0.43 20.38 20.60,20.17 <0.001 <0.001
Thigh muscle 20.04 20.13,0.04 0.28 20.30 20.43,20.16 <0.001 0.002
HOMA2-IR 0.15 0.08,0.22 <0.001 0.35 0.24,0.47 <0.001 0.001
Clinical 1 subclinical CHD VAT 1.08 0.84,1.41 0.54 1.32 1.00,1.75 0.05 0.27
Thigh muscle 0.82 0.65,1.04 0.12 0.73 0.56, 0.94 0.02 0.37
Clinical 1 subclinical CHD VAT 0.99 0.75, 1.28 0.88 1.10 0.80, 1.51 0.55 0.84
Thigh muscle 0.82 0.64,1.04 0.10 0.70 0.53,0.93 0.01 0.37
HOMA2-IR 1.23 1.00,1.54 0.06 1.45 1.14,1.84 0.002 0.27
CRP VAT 0.17 0.07,0.27 0.001 0.25 0.13,0.37 <0.001 0.37
Thigh muscle 20.13 20.22,0.03 0.009 20.07 20.20,0.04 0.21 0.60
CRP VAT 0.17 0.06,0.28 0.002 0.25 0.11,0.38 <0.001 0.84
Thigh muscle 20.12 20.23,0.02 0.01 20.07 20.19,0.05 0.25 0.58
HOMA2-IR 20.01 20.11,0.07 0.73 0.01 20.10,0.11 0.89 0.40
OR/standardised b for a 1SD increase of independent variables; age, sex, height, fat massadjusted.
aP for ethnicity interaction, VAT5abdominal visceral adipose tissue, SSAT5abdominal superficial subcutaneous adipose tissue, TSAT5thigh subcutaneous adipose tissue
HbA1c, CRP,VAT, SSAT, TSAT log-transformed.
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[these ethnic differences in exercise have been previously noted (34)].
A paradoxically raised intramyocellular lipid content (IMCL) is seen
in endurance-trained athletes (35). Yet both ethnic groups showed
inverse relationships between each fat depot and physical activity.
South Asians had less thigh muscle lean tissue when compared with
Europeans, reflecting previous findings (10).
Most ectopic depots had adverse effects on cardiometabolic risk.
VAT was the strongest independent correlate of cardiometabolic risk
and was more strongly associated with HbA1c in South Asians than
Europeans. This fits with the results of a small study (n520) which
indicated that VAT may have a more marked adverse effect on insu-
lin resistance in South Asians than Europeans (10). Previous work
comparing associations between VAT and CRP in Europeans and
South Asians showed similar effects in both groups (36), though our
findings suggest the associations may be stronger in South Asians.
South Asians have larger, less insulin-sensitive adipocytes than
Europeans (9,11). Thus adverse functional capacity coupled with
greater amounts of VAT in South Asians may contribute in tandem
to their excess cardiometabolic risk (9).
We and others have shown that TSAT is protective for diabetes and
HbA1c, but this association only emerges when VAT is accounted for
(12,16). In addition, we demonstrated that protective effects of TSAT
are greater in South Asians than Europeans, though it is unclear why.
As far as we are aware, no studies have compared thigh adipocytes
in these groups, and favorable differences in South Asians may exist,
as unfavorable ones do for abdominal adipocytes (9,11). Matching
our findings, previous studies have reported detrimental associations
between TIMAT or LAM and metabolic risk factors, which do not
remain after adjustment for abdominal fat depots (12,15,17).
Thigh muscle appeared to be protectively and independently associ-
ated with diabetes, HbA1c, and CHD in South Asians, and CRP in
TABLE 4 Ethnic differences in diabetes and CHD, adjusted for body composition measures and insulin resistance
Model Factors
Diabetes Clinical plus subclinical CHD
OR 95% CI P OR 95% CI P
1a South Asian ethnicity 3.08 2.37,3.99 <0.001 1.63 1.28,2.08 <0.001
2b South Asian ethnicity 3.78 2.80,5.10 <0.001 1.76 1.33,2.33 <0.001
3b South Asian ethnicity 3.56 2.62,4.83 <0.001 1.71 1.29,2.27 <0.001
VAT 2.09 1.65,2.63 <0.001 1.18 0.98,1.43 0.07
4b South Asian ethnicity 3.19 2.33,4.37 <0.001 1.60 1.20,2.13 0.001
VAT 1.72 1.34,2.20 <0.001 1.06 0.87,1.30 0.55
HOMA2-IR 1.59 1.32,1.90 <0.001 1.35 1.14,1.59 <0.001
5b South Asian ethnicity 3.14 2.28,4.32 <0.001 1.50 1.12,2.02 0.007
Thigh muscle 0.78 0.61,0.98 0.04 0.78 0.65,0.93 0.006
Thigh muscle#ethnicity 0.91 0.69,1.21 0.53 - - -
6b South Asian ethnicity 2.65 1.90,3.69 <0.001 1.35 1.00,1.84 0.05
Thigh muscle 0.74 0.58,0.94 0.01 0.76 0.63,0.91 0.003
Thigh muscle#ethnicity 0.90 0.67,1.21 0.50 - - -
HOMA2-IR 1.82 1.52,2.17 <0.001 1.38 1.18,1.62 <0.001
7b South Asian ethnicity 4.13 3.03,5.65 <0.001 - - -
TSAT 0.77 0.57,1.03 0.08 - - -
TSAT#ethnicity 0.76 0.58,0.99 0.05 - - -
8b South Asian ethnicity 3.60 2.61,4.97 <0.001 - - -
TSAT 0.79 0.58,1.07 0.13 - - -
TSAT#ethnicity 0.73 0.55,0.97 0.03 - - -
HOMA2-IR 1.78 1.49,2.12 <0.001 - - -
9b South Asian ethnicity 2.60 1.86,3.63 <0.001 1.34 0.99,1.83 0.06
VAT 1.72 1.33,2.21 <0.001 1.07 0.87,1.31 0.55
Thigh muscle 0.74 0.59,0.94 0.02 0.76 0.63,0.91 0.003
Thigh muscle#ethnicity 0.91 0.68,1.23 0.55 - - -
HOMA2-IR 1.61 1.34,1.94 <0.001 1.36 1.15,1.61 <0.001
OR for a 1SD increase of independent variables.
aage, sex-adjusted.
bage, sex, height, fat mass-adjusted.
VAT5abdominal visceral adipose tissue, TSAT5thigh subcutaneous adipose tissue, VAT, TSAT, HOMA2-IR log-transformed.
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Europeans. Muscle mass has previously been shown to be negatively
associated with inflammatory markers (18). Previous studies have
shown that thigh muscle density (in Europeans) and total lean mus-
cle mass (in South Asians) are positively associated with insulin
sensitivity (14,37); suggesting this as a mechanism for muscle being
protective for cardiometabolic traits. However, when we adjusted for
insulin resistance, thigh muscle retained beneficial associations with
HbA1c and CHD—though there may have been residual confounding
as calculated measures of insulin resistance are imprecise. Another
explanation for these cross-sectional findings is reverse causality,
i.e. diabetes/CHD leading to reduced physical activity, and thus
reduced muscle area. However, in sensitivity analyses where multi-
variable models were adjusted for physical activity, protective associ-
ations for thigh muscle remained. Additionally, strong negative linear
associations between thigh muscle and HbA1c were observed, well
into the normoglycaemic range, arguing against reverse causality. As
there is evidence that lower cardiorespiratory fitness in South Asians
when compared to Europeans may explain their adverse metabolic
profile (33), we further adjusted multivariable models for heart rate,
as a proxy for fitness. This did not alter the results, though the lack
of a direct measure of cardiorespiratory fitness is a limitation of this
study. The greater beneficial effects of muscle on metabolic measures
in South Asians compared with Europeans are unexplained.
Our earlier longitudinal analysis showed that central obesity, as
measured by waist-hip ratio, only partly accounted for the excess
diabetes incidence in South Asians (5). We explored this association
using the more precise measure of VAT, and again demonstrated
some attenuation of the ethnic difference. Thigh muscle also
explained some of ethnic difference when added to the model, as
South Asians had less of this protective depot. Conversely, inclusion
of TSAT increased the South Asian diabetes excess. This suggests
that the greater amount of this apparently favorable depot provides
some protection from diabetes in South Asians; bringing their levels
of TSAT down to that of Europeans would increase their risk of dia-
betes. Adjustment for insulin resistance attenuated but did not abol-
ish the relationship between VAT and diabetes, suggesting insulin
resistance does not wholly mediate the association with diabetes. A
novel finding is that the effects of TSAT and thigh muscle on the
excess diabetes risk in South Asians were independent of VAT or
insulin resistance. This suggests that the apparent protective effects
of TSAT and thigh muscle act on a different pathway to the adverse
effects of VAT, and warrants further exploration. It is possible that
thigh muscle acts as a marker for cardiorespiratory fitness, which
predicts outcomes independently of physical activity (38). Similarly,
while VAT accounted for some of the ethnic difference in CHD,
much of the difference remained unexplained, and the impact of
VAT appeared to act via insulin resistance. The lesser thigh muscle
in South Asians also contributed to their excess CHD, and, unlike
VAT, its effect was independent of insulin resistance.
Strengths of this study include a comparatively large sample (8-12),
accurate CT quantification of body composition measures, and the
examination of many fat depots simultaneously on several cardiome-
tabolic traits. We provide a more representative sample than previ-
ous similar research, as our participants were recruited at baseline
(1988–1991) through population stratified random sampling, unlike
other studies which limited their recruitment to healthy volunteers
(7-11). These analyses were performed on participants at the follow-
up clinic (2008–2011), thus bias may have been introduced by loss
to follow-up, although proportions of baseline participants available
for these analyses did not differ by ethnicity (30% of South Asians
and 29% of Europeans). If we restricted our sample to those without
previously diagnosed diabetes or CHD or not in receipt of lipid-
lowering medication, only 26% of South Asians, and 49% of Euro-
peans remained (ethnic difference P < 0.001). Such restrictions
therefore have the potential to introduce important ethnic biases, and
reduce generalizability of findings. Our population was relatively
elderly, compared to previous studies (7-11), appropriate given this
group suffer more cardiometabolic disease. Some associations may
have altered as a result of disease or treatment. Measurement error
may have been introduced by the use of bioimpedance to quantify
body fat in South Asians—as far as we know, this method has not
been validated in this group. This study only examined cross-
sectional associations; therefore we cannot infer causality and fur-
ther longitudinal research is needed to replicate the findings.
In summary, as well as greater levels of detrimental abdominal vis-
ceral adipose tissue (VAT), South Asians have greater levels of pro-
tective TSAT, and lesser levels of protective skeletal muscle than
Europeans. In South Asians these depots act independently on cardi-
ometabolic risk and their effects appear markedly greater than in
Europeans. Insulin resistance contributed to the effects of VAT on
cardiometabolic risk, but not to the effects of TSAT or thigh muscle.
In combination, depots, particularly VAT and muscle, contributed to
but could not wholly explain the South Asian excess of diabetes and
CHD. Explanations for the marked protective effects of TSAT and
muscle on cardiometabolic traits in South Asians should be urgently
sought, as these may provide novel insights and targets for interven-
tion in this high risk population.
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